Nivagen Pharmaceuticals, Inc.
Meet Kanojia is a Quality Assurance Chemist at Nivagen Pharmaceuticals, Inc., with a focus on corporate quality assurance, managing change control, deviations, audits, compliance for contract manufacturing organizations, batch releases, market complaints, and developmental QA activities since April 2021. Previously, Meet Kanojia served as a Senior Research Associate and Research Associate at Intas Pharmaceuticals, where responsibilities included batch release for the EU market, handling market complaints, change controls, deviations, audit compliance, and artwork preparation from September 2016 to March 2021. Early experience includes a role as Quality Assurance Executive at Alembic Pharmaceuticals Limited from July 2015 to September 2016, focusing on in-process quality assurance, documentation, and annual product quality reviews. Meet Kanojia holds a Master’s Degree in Quality Assurance and Regulatory Affairs from Nirma University, completed in 2015.
Nivagen Pharmaceuticals, Inc.
Nivagen is engaged in the development, acquisition, and sales of generic prescription drugs and over the counter products for the North American market. It envisions to deliver high-quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.The US genericprescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in the next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, they can provide cost savings to the consumer while creating value for all members of the supply chain.